FDA Warning Letter — N.Y.S. Psychiatric Institute IRB

Case 670989 — FEI 2431841

The FDA took a Warning Letter action against N.Y.S. Psychiatric Institute IRB on March 21, 2024 (New York, NY). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
N.Y.S. Psychiatric Institute IRB
Date
March 21, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)